Citation Impact

Citing Papers

Thematic Review Series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis
2008
International Consensus Study of Antipsychotic Dosing
2010
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
New insights into pancreatic cancer-induced paraneoplastic diabetes
2013
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development
2015
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
2008
DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation
2010
NF-κB signaling in inflammation
2017 Standout
Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study
2006
Comparative efficacy of antipsychotics in the treatment of schizophrenia: A critical assessment
2005
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
2004
Investigation of ifosfamide nephrotoxicity induced in a liver–kidney co‐culture biochip
2012
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
2009
Schizophrenia
2009 Standout
The 'atypicality' of antipsychotics: a concept re-examined and re-defined
2009 Nobel
The Human Obesity Gene Map: The 2005 Update
2006
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia
2006
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Partial Protein-Hydrolyzed Infant Formula Decreased Food Sensitization but Not Allergic Diseases in a Prospective Birth Cohort Study
2010
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Schizophrenia
2004
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
2008 Standout
New Ways to Detect Adverse Drug Reactions in Pediatrics
2012
Pancreatic cancer
2016 Standout
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
2008
Psychedelics
2016 Standout
The REDCap consortium: Building an international community of software platform partners
2019 Standout
Five Years of GWAS Discovery
2012 Standout
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
2014 Standout
The two faces of the pharmacological interaction of mGlu2 and 5-HT2A – Relevance of receptor heterocomplexes and interaction through functional brain pathways
2013
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
In Vitro–In Vivo Correlations of Scalable PLGA-Risperidone Implants for the Treatment of Schizophrenia
2010
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
2010 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Dynamics and functions of lipid droplets
2018 Standout
Microfluidic organs-on-chips
2014 Standout
Short Neuropeptide F Is a Sleep-Promoting Inhibitory Modulator
2013 StandoutNobel
Rethinking schizophrenia
2010 StandoutNature
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
Pharmacological treatment strategies for schizophrenia
2004
Social functioning as an outcome measure in schizophrenia studies
2007
Early-Onset Hypothesis of Antipsychotic Drug Action: A Hypothesis Tested, Confirmed and Extended
2005
Use of Voriconazole in the Treatment of Fungal Keratitis
2007
NPY receptors as potential targets for anti‐obesity drug development
2011
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Voriconazole in the treatment of fungal eye infections: a review of current literature
2008
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
2009 Standout
Single-Dose Pharmacokinetics of Daptomycin in Children With Suspected or Proved Gram-Positive Infections
2008
Type 2 diabetes mellitus
2015 Standout
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
2008
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications
2010
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
2006
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
New insights in the pathogenesis of non-alcoholic fatty liver disease
2006
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
2013 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
Industry sponsorship and research outcome
2012 Standout
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice
2005
Cerebrospinal Fluid and Plasma (1→3)-β-d-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental HematogenousCandidaMeningoencephalitis
2008
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
2008
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance
2007
DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates Lipotoxicity
2009
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes
2014
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
2011 Standout
Diacylglycerol acyl transferase 1 overexpression detoxifies cardiac lipids in PPARγ transgenic mice
2012
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Haloperidol dose for the acute phase of schizophrenia
2013
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases
2014
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment
2006
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
2015
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
2007
Industry sponsorship and research outcome
2017 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout

Works of Nancy Chen being referenced

The Effects of Olanzapine on the 5 Dimensions of Schizophrenia Derived by Factor Analysis
2001
Drug-Induced Nephrotoxicity in Children
2007
N‐acetylcysteine as a Novel Prophylactic Treatment for Ifosfamide‐Induced Nephrotoxicity in Children: Translational Pharmacokinetics
2011
Gastrointestinal tolerance of a new infant milk formula in healthy infants: multicenter study conducted in Taiwan
2002
Lymphatic Transport and Catabolism of Therapeutic Proteins after Subcutaneous Administration to Rats and Dogs
2012
Ontogeny of drug elimination by the human kidney
2005
Dose Response and Dose Equivalence of Antipsychotics
2004
The effect of the neonatal Fc receptor on human IgG biodistribution in mice
2014
Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention
2009
Issues that May Determine the Outcome of Antipsychotic Trials: Industry Sponsorship and Extrapyramidal Side Effect
2007
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Topical Voriconazole as a Novel Treatment for Fungal Keratitis
2005
The Complex Exocrine–Endocrine Relationship and Secondary Diabetes in Exocrine Pancreatic Disorders
2011
Whole-body Insulin Resistance in the Absence of Obesity in FVB Mice With Overexpression of Dgat1 in Adipose Tissue
2005
A randomized, double‐blind, placebo‐controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use
2011
Rankless by CCL
2026